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Abstract 
Background: The Life Extension Medical Decision law enacted on February 4, 2018 in South Korea was the first to 
consider the suspension of futile life-sustaining treatment, and its enactment caused a big controversy in Korean soci-
ety. However, no study has evaluated whether the actual implementation of life-sustaining treatment has decreased 
after the enforcement of this law. This study aimed to compare the provision of patient consent before and after the 
enforcement of this law among cancer patients who visited a tertiary university hospital’s emergency room to under-
stand the effects of this law on the clinical care of cancer patients.
Methods: This retrospective single cohort study included advanced cancer patients aged over 19 years who visited 
the emergency room of a tertiary university hospital. The two study periods were as follows: from February 2017 to 
January 2018 (before) and from May 2018 to April 2019 (after). The primary outcome was the length of hospital stay. 
The consent rates to perform cardiopulmonary resuscitation (CPR), intubation, continuous renal replacement therapy 
(CRRT), and intensive care unit (ICU) admission were the secondary outcomes.
Results: The length of hospital stay decreased after the law was enforced from 4 to 2 days (p = 0.001). The rates of 
direct transfers to secondary hospitals and nursing hospitals increased from 8.2 to 21.2% (p = 0.001) and from 1.0 to 
9.7%, respectively (p < 0.001). The consent rate for admission to the ICU decreased from 6.7 to 2.3% (p = 0.032). For CPR 
and CRRT, the consent rates decreased from 1.0 to 0.0% and from 13.9 to 8.8%, respectively, but the differences were 
not significant (p = 0.226 and p = 0.109, respectively).
Conclusion: After the enforcement of the Life Extension Medical Decision law, the length of stay in the tertiary uni-
versity hospital decreased in patients who established their life-sustaining treatment plans in the emergency room. 
Moreover, the rate of consent for ICU admission decreased.
Keywords: Life Extension Medical Decision law, Length of hospital stay, Cardiopulmonary resuscitation, Intubation, 
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Background
Cancer is one of the three leading causes of death in 
South Korea, with more than 210,000 newly diagnosed 
cases every year [1, 2]. In 2020, nearly 10 million people 
died from cancer worldwide, with approximately one in 
six deaths being due to cancer [3]. The death burden due 
to cancer is heavy despite early diagnosis and prompt 
treatment [4]. Cancer patients receive rigorous chemo-
therapy and thus, incur high treatments costs and expe-
rience prolonged hospital stays compared to patients 
with other illnesses [5]. Therefore, it is important for 
cancer patients to make decisions regarding their direc-
tion of treatment, considering an improved quality of life 
and how they wish to spend the rest of their lives. That 
is, patients have the right to refuse futile life-sustaining 
treatments and such decisions should be made after thor-
ough discussions between the patient, their family, and 
the involved medical professionals. In addition, the sus-
pension of life-sustaining treatments must be guaranteed 
by an unbiased social system in consideration of the rel-
evant ethical aspects.
However, in practice, patients in Korea are rarely 
involved in the decision to refuse life-sustaining treat-
ments. Several studies on terminal cancer patients 
have shown that family members and medical profes-
sionals make this decision without sufficient discus-
sion with the patient [6]. Furthermore,  until now, there 
have been no laws pertaining to life-sustaining treat-
ments, making it difficult to respect the patients’ right to 
self-determination.
Consequently, the Life Extension Medical Decision 
(LEMD) law, regarding the decisions on hospice care, pal-
liative care, and life-sustaining medical care for patients 
close to death, was enforced on February 4, 2018, as an 
institutional measure to respect the dignity and rights of 
patients in South Korea [7]. It provides legal provisions 
describing the criteria, conditions, and methods for dis-
continuing futile life-sustaining care. The enforcement of 
this law resulted in a big controversy in the Korean soci-
ety because this law respects the patient’s right to self-
determination and increases the likelihood of patients 
dying comfortably while maintaining human dignity.
Since the value of a patient’s life is influenced by 
social consensus, which differs by culture, regulations 
related to life-sustaining medical care differ across coun-
tries. A similar law was passed in the United States. In 
1976, the Natural Death Act was passed in California, 
United States, and it was the first law to legally con-
sider a patient’s letter of intent to discontinue medical 
care [8]. In addition, the Patient Self-Determination Act 
was passed in 1990, respecting patients’ decisions and 
allowing them the independence to refuse treatment. A 
recent systematic review reported that between 2011 and 
2016, 36.7% of US adults completed advance directives, 
of whom 29.3% had living wills [9]. Therefore, with the 
enactment of the LEMD law, changes such as a decrease 
in the use of life-sustaining treatments and an increase 
in written consent for orders for Life-Sustaining-Treat-
ment (orders for LST) are expected in South Korea. It is 
essential to comparatively analyze the types of changes 
observed in response to the enactment of this law in clin-
ical practice. In particular, previous studies have shown 
that terminal cancer patients account for the highest pro-
portion of patients receiving life-sustaining treatments 
(33.2%); therefore, analyzing the influence of the enact-
ment of the LEMD law on the use of life-sustaining treat-
ments in advanced cancer patients would have significant 
implications in the clinical setting [10].
However, in Korea, research has not been conducted 
on whether the enactment of the LEMD law has shown 
practical effectiveness by comparing the conditions 
before and after the enforcement of this law. Therefore, 
in this study, we aimed to compare relevant parameters, 
such as the length of hospital stay; rates of consent to 
perform cardiopulmonary resuscitation (CPR), intuba-
tion, continuous renal replacement therapy (CRRT), and 
intensive care unit (ICU) admission; and the rate of sur-
vival to discharge, before and after the enforcement of 
the LEMD law in advanced cancer patients who visited 
the emergency room (ER) of a tertiary university hospital.
Methods
Study design
This retrospective single cohort study was conducted at a 
tertiary university hospital. To compare the effects of the 
LEMD law, the 1-year periods before and after enforce-
ment were selected as the target research periods; the 
period of 3 months immediately after the enforcement of 
the LEMD law was considered the adaptation period and 
thus, excluded from the study. Therefore, the two final 
study periods were as follows: from February 2017 to 
January 2018 (before) and from May 2018 to April 2019 
(after).
Primary comparisons were made between these two 
study periods. The patients from each period were 
divided into two groups: one group included patients 
who had signed orders for LST or prepared advance 
directives before visiting the ER, and the other group 
included patients who signed their orders for LST or 
established their life-sustaining treatment plan during 
their ER visit.
The study data were collected using the Severance 
Clinical Research Analysis Portal, the clinical data 
search system used by the hospital. This study was 
conducted in compliance with the Declaration of Hel-
sinki, and the need for informed consent was waived 
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due to the study’s retrospective design. This study was 
approved by the Institutional Review Board of the Yon-
sei University Health System (approval number 4-2020-
0630). The need for informed consent was waived by 
the Institutional Review Board of the Yonsei University 
Health System (approval number 4-2020-0630).
Participants
Advanced cancer patients aged over 19 years with stage 
IV or metastatic cancer who visited the ER of Sever-
ance Hospital during the study periods were included 
in this study.
Overall, the analyzed patients included the follow-
ing: (1) patients who visited the ER between Febru-
ary 2017 and January 2018, before the enforcement of 
LEMD law, with signed orders for LST obtained prior 
to or during the ER visit and (2) patients who visited 
the ER between May 2018 and April 2019, after the 
enforcement of the law, with advance directives pre-
pared beforehand or life-sustaining treatment plan 
established during the ER visit. Among these, cases in 
which the consent form was signed but the exact infor-
mation could not be confirmed owing to incomplete 
item descriptions were excluded.
Outcomes
We investigated the length of hospital stay as the primary 
outcome. In addition, the consent rates to perform CPR, 
intubation, CRRT, and ICU admission were considered 
as secondary outcomes, to confirm whether the con-
sent rates for life-sustaining treatments and life-sustain-
ing procedures actually reduced with the enactment of 
the LEMD law. Furthermore, variables such as the time 
taken from reception to the completion of orders for LST 
or a life-sustaining treatment plan, length of stay in the 
ER, transfer from the ER to secondary or nursing hospi-
tals, survival rate in the ER, and medical expenses were 
also analyzed.  “Medical expenses” referred to the total 
expenses incurred during hospital stay, including ER 
expenses, during the study periods. The calculations were 
made collectively by the hospital’s accounting team.
Description of each consent form
Provision of orders for LST before the enforcement 
of the LEMD law
Orders for LST enforce the abandoning of resuscita-
tion attempts in patients with no prospect of resuscita-
tion, especially in patients with predicted cardiac arrest 
[11]. This document has an arbitrary format used widely 
by medical institutions in clinical practice; however, the 
subject and format are not universal. In addition, before 
the enforcement of the law, there was no difference 
in either the title or detailed items between the form 
received in advance and the one received in the ER.
Provision of advance directives after the enforcement 
of the LEMD law
This form is to be completed at an outpatient depart-
ment or other medical agencies prior to an ER visit. Any 
adult aged ≥ 19 years can document his or her intentions 
for life-sustaining treatments and hospice care directly in 
preparation for a situation in which the person becomes 
a patient at the end of life in the future. The document 
prepared for this purpose is called the advance directive 
on life-sustaining treatments and should be created after 
receiving sufficient explanation through the Registry 
Agencies for Advance Directives designated by the Min-
istry of Health and Welfare. The legal validity of the cre-
ated and registered advance directives can be recognized 
only when they are stored in the database of the life-sus-
taining treatments information processing system [7].
Provision of a life-sustaining treatment plan after the 
enforcement of the LEMD law
This form is to be filled out when a patient who has not 
previously completed advance directives visits the ER. If 
the patient is conscious, the patient’s preference is noted. 
If the patient is unconscious, the form is filled out after 
discussion between the guardian and doctor.
According to the decision of the terminally ill patient, 
the doctor-in-charge plans and documents the decisions 
related to the patient’s life-sustaining medical treatment 
and hospice care [7], and this process is shown in Fig. 1 
[12].
As shown in Fig. 1, if a patient who has not indicated 
an intention to withhold life-sustaining treatments in 
advance is unconscious, a decision can be made only 
after all family members come to a unanimous agreement 
(Table 1).
Statistical analysis
The collected data were analyzed using the SAS soft-
ware (version 9.4, SAS Inc., Cary, NC, USA). All con-
tinuous variables except age did not satisfy the normality 
assumption; thus, the variables were analyzed using the 
Wilcoxon rank-sum test, and the results were pre-
sented as medians (Q1, Q3). Age was presented as the 
mean ± standard deviation. Categorical variables were 
analyzed using the chi-square test (Fisher’s exact test) 
and presented as counts (%). The Monte Carlo estimation 
method was used to accurately determine the location 
of the primary cancer. A p value < 0.05 was considered 
significant.
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Results
During the study period, a total of 1443 patients with 
stage IV advanced cancer or metastatic cancer were 
admitted to the hospital’s ER. Overall, 433 and 1010 
patients visited the hospital before (February 2017–
January 2018) and after (May 2018–April 2019) the 
enforcement of the LEMD law, respectively. Prior to 
enforcement, 197 patients had prepared orders for LST 
in advance or in the ER, while after the enforcement of 
the LEMD law, 220 patients had prepared advance direc-
tives before visiting the ER or established a life-sustaining 
treatment plan in the ER. Of these, five patients (two, 
before enforcement; three, after enforcement) were 
excluded from the study due to incomplete informa-
tion on the forms. Finally, 195 patients presenting before 
enforcement and 217 patients presenting after enforce-
ment were included in this study. Of the 195 patients 
presenting before enforcement, 20 had completed orders 
for LST before visiting the ER and 175 did so in the ER. 
Of the 217 patients presenting after enforcement, 78 had 
prepared advance directives before visiting the ER and 
Fig. 1 Procedure of decision-making regarding withholding life-sustaining treatment
Table 1 Comparison of details of the consent forms
LST Life-Sustaining-Treatment, CPR cardiopulmonary resuscitation, CRRT continuous renal replacement therapy, ICU intensive care unit, LEMD law Life Extension 
Medical Decision law
Orders for  LSTa: Before the enforcement of the LEMD law, each hospital had its own independent consent form. The items described above are based on the format 
used at our hospital
Orders for  LSTa (before the enforcement of the LEMD law) Advance directives or life-sustaining 
treatment plan after the enforcement of the 
LEMD law
CPR CPR
Endotracheal intubation and ventilator care Ventilator care
CRRT Hemodialysis
Administration of anti-cancer drugs
Vasopressor and inotropic agent use
Increased vasopressor and inotropic agent use
Transfusion
Blood test
ICU care ICU care
Page 5 of 11Chung et al. BMC Med Ethics           (2021) 22:72  
139 wrote their life-sustaining treatment plan in the ER 
(Fig. 2).
The basic characteristics of the patients enrolled in this 
study before and after the enforcement of the LEMD law 
are shown in Table 2.
We compared patients who completed their orders 
for LST, before or during the ER visit, in the pre-
enforcement period with patients who completed their 
advance directives before the ER visit or created their 
life-sustaining treatment plan during the ER visit in the 
post-enforcement period.
After the enforcement of the LEMD law, the time 
taken to obtain consent forms (orders for LST before 
enforcement/advance directives or life-sustaining treat-
ment plan after enforcement) was reduced to 3  h and 
52 min from 4 h and 33 min (p = 0.031); conversely, the 
length of stay in the ER increased from 13 h and 37 min 
to 19  h and 55  min (p = 0.006). The length of stay in 
the hospital decreased from 4 to 2  days (p = 0.001), 
along with a decrease in medical expenses (p = 0.008). 
Furthermore, the rate of direct transfers from the ER 
to secondary hospitals increased from 8.2 to 21.2% 
(p = 0.001), and that of transfers to nursing hospitals 
increased from 1.0 to 9.7% (p < 0.001) (Table 3).
In addition, the consent rate for ICU admission 
decreased from 6.7% before enforcement to 2.3% after 
enforcement (p = 0.032). After the enforcement of the 
LEMD law, a large number of patients were found to sur-
vive until discharge, and this difference was highly signifi-
cant (p = 0.001) (Table 3).
We performed subgroup analyses according to the 
place where the consent form was signed. On comparing 
only those patients who established orders for LST (pre-
enforcement) or life-sustaining treatment plan (post-
enforcement) in the ER, we found that the time taken 
from reception to signing the orders for LST was 4 h and 
56 min before enforcement, while the same task (creating 
Fig. 2 Flow diagram of patient eligibility. LST life-sustaining-treatment, ER emergency room, OPD outpatient department
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a life-sustaining treatment plan) took significantly longer 
(7 h and 46 min) after enforcement (p < 0.001). Consist-
ent with the results of the overall comparison, the length 
of stay in the ER increased from 14 h and 24 min (before 
enforcement) to 23  h and 11  min (after enforcement) 
(p = 0.003), but the length of hospital stay decreased 
from 4 to 2 days (p = 0.001). The rates of direct transfers 
from the ER to secondary hospitals and nursing hospitals 
also increased in the period after enforcement, from 9.1 
to 20.1% (p = 0.005) and from 1.1 to 10.1% (p = 0.001), 
respectively. The survival rate in the ER decreased from 
88.6 to 80.6% after the law was implemented (p = 0.049) 
(Table  4). The proportion of life-sustaining treatments 
or life-sustaining procedures specified in the orders for 
LST or life-sustaining treatment plan decreased overall 
after enforcement, but this difference was not statistically 
significant. However, there was a significant reduction 
in the consent rate for ICU admission, from 6.9 to 1.5% 
(p = 0.026) (Table 4).
Next, we analyzed the results of the following two 
groups: those who had prepared orders for LST before 
visiting the ER in the pre-enforcement period and those 
who had prepared advance directives before visiting 
the ER in the post-enforcement period. The length of 
stay in the ER increased from 8 h and 30.5 min (before 
enforcement) to 16  h and 10.5  min (after enforcement) 
(p = 0.042). The rate of transfer from the ER to a sec-
ondary hospital increased from 0.0 to 23.1% (p = 0.020). 
Lastly, the rate of survival to discharge showed a highly 
significant increase from 15 to 62.8% after the enforce-
ment of the LEMD law (p = 0.001) (Table 5). Because the 
patients included in this comparative analysis had pre-
pared their consent forms (orders for LST or advance 
directives) in advance, the time taken to complete the 
consent forms was not evaluated.
Discussion
On February 4, 2018, the “Act on Hospice and Palliative 
Care and Decisions on Life-sustaining Treatment for 
Patients on End of Life (Life Extension Medical Deci-
sion Law)” came into force in South Korea [7]. This was 
the first law to consider the suspension of futile life-sus-
taining medical care, which raised a big issue both in the 
medical field and the social community.
If consent was received in the ER, the time taken to 
obtain consent for a life-sustaining treatment plan was 
longer after enforcement of the LEMD law than the time 
taken to establish orders for LST before the law was 
enforced. Additionally, the length of stay in the ER was 
longer after enforcement. In contrast, the percentage 
Table 2 Patient characteristics before and after the enforcement of the LEMD law
Data are presented as the mean ± standard deviation or n (%)
LST Life-Sustaining-Treatment, LEMD law Life Extension Medical Decision law
Variables Group p value
Orders for LST before 
enforcement of the LEMD law 
(n = 195)
Advance directives or life-sustaining treatment 
plan after enforcement of the LEMD law (n = 217)
Age (years) 68.3 ± 11.5 63.0 ± 7.7 0.159
Sex, male 107 (54.9) 100 (46.1) 0.178
Primary cancer 0.599
 Pancreatic cancer 15 (7.69) 18 (8.3)
 Gastric cancer 24 (12.3) 16 (7.4)
Head, neck, and oral cancers 6 (3.08) 8 (3.7)
 Liver and intrahepatic bile duct cancers 25 (12.8) 37 (17.1)
 Lung, tracheal, and bronchial cancers 47 (24.1) 46 (21.2)
 Hematologic cancer 1 (0.5) 1 (0.5)
 Esophageal cancer 2 (1.0) 3 (1.4)
 Colorectal cancer 21 (10.8) 36 (16.6)
 Breast cancer 19 (9.7) 14 (6.5)
 Prostatic cancer 3 (1.5) 5 (2.3)
 Uterus, ovarian, and cervical cancers 8 (4.1) 12 (5.5)
 Kidney cancer 5 (2.6) 3 (1.4)
 Bladder cancer 3 (1.5) 3 (1.4)
 Skin cancer 3 (1.5) 6 (2.8)
 Others 13 (6.7) 9 (4.2)
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of transfers to other hospitals increased and the length 
of hospital stay decreased after the LEMD law was 
enforced. There were no significant differences in con-
sent rates for most LSTs and life-sustaining procedures 
before and after enforcement; however, the consent rate 
for ICU admission decreased after enforcement. The rate 
of survival to discharge was particularly high in the group 
of patients who had completed advance directives before 
the ER visit.
The time from ER registration to signing the life-sus-
taining treatment plan was longer after the enforcement 
of the LEMD law, and this can be attributed to the pecu-
liarity of the legal system. In the period immediately after 
enforcement, not many patients had prepared such docu-
ments in advance, and many severely ill patients were 
unconscious at presentation; thus, it took a long time for 
all family members to come to a unanimous decision. 
However, after a certain time period, even in the absence 
of advance directives, the patient’s will to withdraw 
life-sustaining treatments was recorded in the medical 
record in many cases or more patients informed family 
members in advance. Thus, it was possible to withdraw 
life-sustaining treatments at a relatively early stage with a 
decision statement from only two family members [7]. If 
the time to finalize consent is prolonged, the length of ER 
stay also increases, which may cause overcrowding in the 
ER [13]. This clearly indicates the need for a simplified 
procedure for preparing a life-sustaining care scheme. 
As an alternative, there could be a way for patients to 
appoint a specific guardian (family member or friend) 
in advance and give them the right to make decisions 
in critical situations. In Queensland, the Guardianship 
and Administration Act 2000 allowed competent adults 
to give an enduring power of attorney regarding health 
matters to any person of their choice (family member or 
friend), allowing the selected person to make decisions in 
case patients lose their decision-making abilities. If nec-
essary, the Guardianship Tribunal can appoint a guardian 
if no person has been selected by the patients themselves 
[14]. This concept is not yet considered appropriate in 
the context of the traditional culture in Korea, but it may 
become more suitable in future.
In this study, the increase in the length of ER stay can 
be understood in relation to the increase in the rate of 
direct transfer from the ER to other hospitals. Before 
the LEMD law was implemented, the rate of transfer to 
Table 3 Comparison of parameters before and after the enforcement of the LEMD law
Data are presented as the median (Q1, Q3) for continuous variables and number (%) for categorical variables
LST Life-Sustaining-Treatment, CPR cardiopulmonary resuscitation, CRRT continuous renal replacement therapy, ICU intensive care unit, ER emergency room, OPD 
outpatient department
Variables Group p value
Orders for LST before 
enforcement of the LEMD law 
(n = 195)
Advance directives or life-sustaining treatment 
plan after enforcement of the LEMD law 
(n = 217)
Time taken from reception to obtaining written 
consent (min)
273 (117, 501) 232 (0, 683) 0.031
Length of stay in the ER (min) 817 (447, 1705) 1195 (594, 2151) 0.006
Length of hospital stay (days) 4 (1, 10) 2 (0, 8) 0.001





Type of ER visit 0.860
 Direct visit to the ER without transfer from another 
hospital
144 (73.9) 155 (71.4)
 Transfer from another hospital 46 (23.6) 56 (25.8)
 Transfer from the OPD 5 (2.6) 6 (2.8)
Transfer from the ER to a secondary hospital 16 (8.2) 46 (21.2) 0.001
Transfer from the ER to a nursing hospital 2 (1.0) 21 (9.7) < 0.001
Survival in the ER 173 (88.7) 186 (85.7) 0.363
Life-sustaining treatments and life-sustaining 
procedures
 Consent to perform CPR 2 (1.0) 0 (0.00) 0.226
 Consent to perform intubation 10 (5.1) 11 (5.1) 0.995
 Consent to perform CRRT 27 (13.9) 19 (8.8) 0.109
 Consent for ICU admission 13 (6.7) 5 (2.3) 0.032
Survival at discharge 56 (28.7) 96 (44.2) 0.001
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a secondary hospital was only 8.2% and that of trans-
fer to a nursing hospital was 1.0%, but the correspond-
ing rates increased to 21.2% and 9.7%, respectively, after 
implementation (Table  3). Considering that the length 
of ER stay increased similarly in the group of patients 
who prepared advance directives in advance, longer stay 
in the ER is a separate issue from the time required to 
complete the consent form. The increase in the number 
of direct transfers to other hospitals, especially nursing 
hospitals, is the most likely cause for this result. In South 
Korea, transfer to nursing hospitals is mostly possible 
during regular consultation sessions, and patients have 
to wait until regular hours; therefore, selection of a nurs-
ing hospital takes up an inordinate amount of time. An 
increase in the length of ER stay causes overcrowding 
[13]. This can lead to a reduction in the ER’s capacity to 
accommodate patients, disruption of medical practice for 
those in urgent need of treatment, and an increase in the 
mortality rate [15]. A previous study suggested the use of 
alternative care facilities as one of the ways to resolve ER 
overcrowding. This has been shown to not only reduce 
waiting times and medical expenses but also improve 
patient outcomes and satisfaction with the medical staff 
[15]. In other words, rather than staying in the ER while 
waiting for hospitalization or transfer to other hospitals, 
direct admission to the hospital’s hospice ward could be 
a good option for patients who have already prepared 
advance directives or a life-sustaining treatment plan. 
However, in our hospital, we have no choice but to keep 
patients waiting in the ER due to the absence of a hospice 
ward; thus, this area has scope for further improvement.
We predicted that if the number of patients who pre-
pared advance directives or a life-sustaining treatment 
plan increases, the number of patients discharged to 
nursing hospitals for palliative care or who can receive 
home care will increase, and the length of hospital stay 
will be shortened [16]. This was consistent with the 
results from our study.
As the disease progresses, the hospitalization rate of 
patients increases exponentially, which leads to spending 
more time in the hospital during the last 6 months of life; 
this is especially true for cancer patients [17]. In cancer 
patients, nutrition support or pain control is often the 
most common reason for hospital admission, in addition 
to chemotherapy administration [18]. However, these 
types of symptom control treatments can be adequately 
Table 4 Orders for LST before enforcement and life-sustaining treatment plan after enforcement in the ER
Data are presented as the median (Q1, Q3) for continuous variables and number (%) for categorical variables
LST Life-Sustaining-treatment, CPR cardiopulmonary resuscitation, CRRT continuous renal replacement therapy, ICU intensive care unit, ER emergency room, OPD 
outpatient department
Variable Group p value
Orders for LST prepared in the ER 
before enforcement of the LEMD law 
(n = 175)
Life-sustaining treatment plan prepared in 
the ER after enforcement of the LEMD law 
(n = 139)
Time taken from reception to obtaining written 
consent (min)
296 (155, 532) 466 (245, 963) < 0.001
Length of stay in the ER (min) 864 (479, 1750) 1,391 (642, 2,467) 0.003
Length of hospital stay (days) 4 (1, 9) 2 (0, 6) 0.001
Medical expenses (won) 3,782,083 (1,732,649, 6,638,183) 2,755,304 (1,615,569, 4,823,854) 0.076
Type of ER visit 0.208
 Direct visit to the ER without transfer from 
another hospital
134 (76.6) 94 (67.6)
 Transfer from another hospital 36 (20.6) 40 (28.8)
 Transfer from the OPD 5 (2.9) 5 (3.6)
Transfer from the ER to a secondary hospital 16 (9.1) 28 (20.1) 0.005
Transfer from the ER to a nursing hospital 2 (1.1) 14 (10.1) 0.001
Survival in the ER 155 (88.6) 112 (80.6) 0.049
Life-sustaining treatments and life-sustaining 
procedures
 Consent to perform CPR 2 (1.1) 0 (0.0) 0.506
 Consent to perform intubation 9 (5.1) 6 (4.4) 0.755
 Consent to perform CRRT 2 (1.1) 0 (0.0) 0.506
 Consent for ICU admission 12 (6.9) 2 (1.5) 0.026
Survival at discharge 53 (30.3) 47 (33.8) 0.505
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provided in secondary and nursing hospitals. From a 
medical professional’s point of view, hospital beds must 
be used for patients who absolutely need treatment in 
tertiary university hospitals, but this is not the case in 
real-world practice as patients and their families demand 
hospitalization at a tertiary university hospital even for 
receiving pain control treatment or supportive care. Of 
course, such requests are rational considering the psy-
chological reassurance related to admission to a hospital 
equipped with doctors and facilities competent enough 
to cope with emergencies; however, admission to a ter-
tiary university hospital solely for receiving supportive 
care can deprive other cancer patients who require more 
invasive and urgent treatment.
Especially, in the case of hospitals without a hospice 
ward, this problem is more serious. A study showed that 
receiving specialized treatment in the ambulatory care 
sector is associated with reduced bed utilization and a 
reduced need for hospitalization, especially in advanced 
cancer patients [17]. Therefore, if patients who have 
already prepared advance directives or a life-sustaining 
treatment plan receive care in a nursing hospital or pri-
mary medical institution, the frequency of unplanned 
hospitalizations in a higher-level hospital can be reduced, 
and other patients can avail treatment opportunities. 
Furthermore, from the patient’s point of view, receiving 
treatment at a specialized facility with caregivers who 
can provide focused hospice care can reduce emotional 
and mental stress [19]. As mentioned above, this could 
be of great help in improving the patient’s quality of life 
[20]. Therefore, it can be inferred that a reduction in the 
length of hospital stay is an important consequence of 
the enactment of the LEMD law and fulfills the purpose 
of the enforcement of this law.
When patients fill out orders for LST, advance directives, 
or the life-sustaining treatment plan, they may refuse all 
ultimate treatments; these forms can generally be seen as 
a means of refusing all life sustaining treatments, but some 
life-sustaining treatments can be selected and received as 
per the patient’s will. Based on previous research, it was 
expected that the consent rates for each treatment would 
differ before and after the implementation of the LEMD 
law [21]. However, this study showed that there was no dif-
ference in the consent rates to perform CPR, intubation, 
and CRRT, although the consent rate for ICU admission 
showed differences before and after enforcement.
Previous international studies have revealed that even 
if a life-sustaining treatment plan has been prepared, 
treatment goals vary widely, subjectively reflecting each 
patient’s will. For example, there are patients who receive 
palliative care only, patients who receive some restrictive 
treatment, and patients who receive all treatments other 
than CPR [22, 23]. However, the procedures described in 
the life-sustaining treatment plan (CPR, intubation, CRRT, 
Table 5 Preparation of orders for LST (pre-enforcement) and advance directives (post-enforcement) before visiting the ER
Data are presented as the median (Q1, Q3) for continuous variables and number (%) for categorical variables
LST Life-Sustaining-treatment, CPR cardiopulmonary resuscitation, CRRT continuous renal replacement therapy, ICU intensive care unit, ER emergency room, OPD 
outpatient department
Variable Group p value
Orders for LST before enforcement 
of the LEMD law (n = 20)
Advance directives after 
enforcement of the LEMD law 
(n = 78)
Length of stay in the ER (min) 510.5 (349.5, 1085) 970.5 (462, 1615) 0.042
Length of hospital stay (days) 5.5 (3, 10) 2 (0, 10) 0.061
Medical expenses (won) 3,593,733.5 (2,439,355.5, 4,899,793.5) 2,167,290.5 (961,601, 6,025,705) 0.133
Type of ER visit 0.025
 Direct visit to the ER without transfer from another hospital 10 (50.0) 61 (78.2)
 Transfer from another hospital 10 (50.0) 16 (20.5)
Transfer from the OPD 0 (0.0) 1 (1.3)
Transfer from the ER to a secondary hospital 0 (0.0) 18 (23.1) 0.020
Transfer from the ER to a nursing hospital 0 (0.0) 7 (9.1) 0.339
Survival in the ER 18 (90.0) 74 (94.9) 0.599
Life-sustaining treatments and life-sustaining procedures
 Consent to perform CPR 0 (0.0) 0 (0.0)
 Consent to perform intubation 1 (5.0) 5 (6.4) > 0.999
 Consent to perform CRRT 0 (0.0) 4 (5.1) 0.579
 Consent for ICU admission 1 (5.0) 3 (3.9) > 0.999
Survival at discharge 3 (15.0) 49 (62.8) 0.001
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and ICU admission) are interconnected. Furthermore, in 
critical situations, it is not easy for patients’ guardians to 
choose only one or two life-sustaining treatment options. 
Besides, there are differences in the scope of treatments 
that patients want to receive depending on the timing of 
preparation of the life-sustaining treatment plan [24]. For 
instance, if a patient visits the ER and prepares a life-sus-
taining treatment plan, there is insufficient time to think 
about how the treatment can be continued. Moreover, 
considering the situation in which a life-sustaining treat-
ment plan is being prepared, it is conceivable that a plan 
prepared in the ER is intended for a patient who is not 
likely to be resuscitated or is dying. In such situations, it is 
extremely difficult to explain the treatments related to the 
patient’s resuscitation to the patient’s guardians, who are 
in despair, and select some of them. Additionally, even if 
guardians select only some of the listed procedures, it may 
not make sense for medical professionals to perform only 
some of those treatments for the aforementioned reasons. 
Therefore, there seems to be no difference in the rate of the 
procedures described in the life-sustaining treatment plan 
before and after the implementation of the LEMD law.
The rate of survival to discharge was significantly 
higher in patients who had prepared advance directives 
before visiting the ER than in patients who prepared the 
life-sustaining treatment plan in the ER. This suggests 
that patients who had prepared advance directives before 
visiting the ER had time to thoroughly ponder about 
the quality of their remaining life. Earlier studies have 
also revealed that the preparation of a letter of intent for 
life-sustaining treatments in advance is associated with 
decreased hospital mortality and an increase in hospice 
use [25], which is equivalent to an increase in the rate 
of survival to discharge. Thus, the patients in this study 
who prepared advance directives before visiting the ER 
wanted an improved quality of life at home or in a hos-
pice facility rather than life-sustaining treatments at a 
university hospital. Although the number of patients in 
this group was small and not statistically significant, the 
reduction in the length of hospital stay by more than half 
can be considered a supporting result. Since the enact-
ment of the LEMD law, an increasing number of patients 
are writing their advance directives beforehand; thus, in 
the future, it is necessary to improve the quality of medi-
cal services for patients receiving palliative care by imple-
menting domestic hospice programs.
Previously, there was no legal system for the suspen-
sion of life-sustaining treatments, and thus, life-sustain-
ing treatments were continued regardless of the patient’s 
will. Alternatively, in cases in which the patient was on 
the verge of death, the designated guardian filled out the 
orders for LST. However, with the implementation of the 
LEMD law, patients have been given the legal right to refuse 
life-sustaining treatments. Near the end of life, intensive 
care for patients who do not want life-sustaining treatments 
imposes physical, emotional, and financial burdens [26, 27], 
which lead to a poor quality of life. Therefore, to improve 
the quality of life of patients with a short life expectancy, 
it is necessary to respect the freedom and will of patients 
who have prepared a life-sustaining treatment plan. This 
approach will also reduce unnecessary admissions to tertiary 
university hospitals, enabling the provision of high-quality 
treatment to other patients who need intensive treatment.
Since the implementation of the LEMD law in South 
Korea, there have been no studies comparing the effects 
of this law and orders for LST (a similar document 
used before implementation), although the number 
of patients who prepare advance directives or a life-
sustaining treatment plan is increasing. Therefore, this 
study has a significant advantage in that it is the first to 
investigate the differences in the consent for orders for 
LST before and after the enforcement of the LEMD law.
There are several limitations to this study. First, this 
study was conducted at one tertiary university hospital 
in South Korea, and thus, the results cannot be general-
ized to the entire country. In subsequent research, con-
tinuing the study in several other university hospitals will 
increase the reliability of the results and contribute to 
generalization. Second, we only included those who had 
prepared orders for LST or advance directives before vis-
iting the ER (outpatient/other institutions) or prepared 
orders for LST or a life-sustaining treatment plan in the 
ER; thus, patients who completed the document in the 
ward after admission through the ER were not included. 
In the follow-up study, it would be interesting to include 
patients who completed the consent form in the ward 
after hospitalization. Third, since the formats for orders 
for LST and advance directives or a life-sustaining treat-
ment plan are different, some detailed procedures were 
excluded from the study (Table 1).
Conclusion
The length of stay in the ER after the enforcement of 
the LEMD law was lengthened both for patients who 
had prepared advance directives before visiting the ER 
and those who completed a life-sustaining treatment 
plan in the ER. In contrast, after the implementation of 
the LEMD law, the length of stay in the tertiary univer-
sity hospital decreased for patients who prepared their 
LST plans in the ER. Moreover, the consent rate for ICU 
admission decreased. However, the consent rates to per-
form CPR, intubation, and CRRT were not significantly 
different before and after the enforcement of the LEMD 
law.
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